TNF and COVID-19: The results of a study showed that from 530 rheumatoid arthritis patients that treated with anti TNF agents (53.7%), 39.3% with other biologic disease-modifying drugs (bDMARDs) and treated with JAK inhibitors (7%) only 3 patients with mild COVID-19 were confirmed that managed at home without any complication in respiratory tract.5